Larry Smith On Stocks, and Boshie, have penned extensive stat analysis to support NWBO is outperforming Optune. I realize that Optune is a device. However, our investment success hinges not on form factor, but rather better results. The article seems to suggest, that the survival outcomes of Optune is not only as good as NWBO, but a game changer in the same disease treatment NWBO is hoping to become SOC to treat.
Market Data 
Markets 
AI
